Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan · Delayed Price · Currency is TWD 40.55
-0.15 (-0.37%)
Oct 31, 2025, 1:30 PM CST
Easywell Biomedicals Market Cap
Easywell Biomedicals has a market cap or net worth of 5.06 billion as of October 31, 2025. Its market cap has decreased by -61.04% in one year.
Market Cap
5.06B
Enterprise Value
5.10B
Revenue
604.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.55
Market Cap Chart
Since February 8, 2007, Easywell Biomedicals's market cap has increased from 447.40M to 5.06B, an increase of 1,030.13%. That is a compound annual growth rate of 13.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 5.06B | -35.47% |
| Dec 31, 2024 | 7.84B | 63.75% |
| Dec 29, 2023 | 4.79B | 160.70% |
| Dec 30, 2022 | 1.84B | -29.34% |
| Dec 30, 2021 | 2.60B | 7.42% |
| Dec 31, 2020 | 2.42B | 94.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |